Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orion
Biotech
Merck inks $1.6B-plus exclusive licensing pact with Orion
Merck is putting more than $1.6 billion biobucks on the table for Orion's cancer candidates targeting CYP11A1.
Gabrielle Masson
Jul 1, 2024 10:38am
Orion realigns stars in top-down organizational restructure
Oct 17, 2022 8:30am
Earnings arrive after dreadful 6 months, but readouts offer hope
Jul 18, 2022 9:42am
Orion's new R&D strategy pays off with $290M Merck deal
Jul 13, 2022 10:00am
Orion inks pain management licensing deal to compete with Vertex
May 6, 2022 9:55am
Orion staff brace for layoffs, program terminations
Mar 24, 2022 7:50am